We are live on ! Find out more
PRPH

ProPhase Labs
PRPH

Delisted

PRPH was delisted on the 2nd of January, 2026.

Back to rankings

16 hedge funds and large institutions have $1.46M invested in ProPhase Labs in 2016 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more funds holding

Funds holding: 14 → 16 (+2)

8% less capital invested

Capital invested by funds: $1.59M → $1.46M (-$126K)

25% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 4

Holders
16
Holders Change
+2
Holders Change %
+14.29%
% of All Funds
0.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
4
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
+$2.56K
2
Bank of America
Bank of America
North Carolina
+$1.02K
3
TRCT
Tower Research Capital (TRC)
New York
+$499
4
Deutsche Bank
Deutsche Bank
Germany
+$418
5
BFA
BlackRock Fund Advisors
California
+$350

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$77.7K
2
Goldman Sachs
Goldman Sachs
New York
-$4.37K
3
UBS Group
UBS Group
Switzerland
-$4.02K
4
Morgan Stanley
Morgan Stanley
New York
-$40

PRPH Hedge Fund Activity: Q2 2016 in Review

16 of the 3,755 institutional investors tracked by Wall St. Rank reported a position in ProPhase Labs (PRPH) for Q2 2016, worth a combined $1.46M — down 7.9% from $1.59M a quarter earlier.

Buyers outnumbered sellers: 2 funds opened new PRPH positions and 0 closed out — a net gain of 2 holders — while 3 added to existing stakes and 4 trimmed.

The largest buyer was Renaissance Technologies, adding an estimated $2.56K. The largest seller was Vanguard Group, cutting an estimated $77.7K.

  • 16 institutional investors held ProPhase Labs (PRPH) as of Q2 2016, up from 14 in Q1 2016.
  • Funds reported $1.46M of ProPhase Labs stock for Q2 2016, down 7.9% quarter-over-quarter.
  • 2 funds opened new ProPhase Labs positions in Q2 2016 and 0 closed out, a net change of +2 holders.
  • The largest ProPhase Labs buyer in Q2 2016 was Renaissance Technologies, an estimated $2.56K added.
  • The largest ProPhase Labs seller in Q2 2016 was Vanguard Group, an estimated $77.7K sold.

Based on aggregated 13F filings for Q2 2016.